- Nanomedicine
-
影響因子:
5.26
-
I S S N:
1743-5889
-
出 版 社:
Future Medicine Ltd.
-
出 版 地:
London, UK
-
出版國家:
England
-
刊 期:
雙月刊
-
創(chuàng)刊時(shí)間:
2006
-
語 種:
英文
-
審稿周期:
約6.0個(gè)月
-
中科院分區(qū):
2
-
投稿命中率:
約25%
-
國外數(shù)據(jù)庫收錄:
IM
-
中國收錄文章數(shù):
21
-
5年影響因子:
6.236
-
研究領(lǐng)域:
納米醫(yī)學(xué)
-
官方鏈接:
http://www.futuremedicine.com/loi/nnm
-
投稿須知:
期刊介紹:
Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.